October 01, 2015
Toronto-based Apotex Inc. violated two of Valeant Pharmaceuticals International Inc.'s patents when it filed an application to make a generic version of Valeant's ulcerative colitis drug Giazo, according to a lawsuit filed in Delaware federal court on Wednesday.